Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 280 clinical trials
featured
TRANSCEND - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - TRANSCEND-CLL-004 - US  

Phase 2 single-arm, multi-cohort study to determine the efficacy and safety of JCAR017 (autologous T cells expressing anti-CD19 chimeric antigen receptor) in adult subjects with aggressive B-NHL (diffuse large B-cell lymphoma (DLBCL) NOS [de novo or transformed follicular lymphoma (tFL)], double/triple-hit lymphoma [DHL/THL], follicular lymphoma Grade 3B [FL3B], primary central …

Georgetown University Medical Center
 (7.9 away)
  • 1875 views
  • 23 Nov, 2020
  • +17 other locations
featured
TRANSCEND - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - TRANSCEND-CLL-004 - US Spanish  

Phase 2 single-arm, multi-cohort study to determine the efficacy and safety of JCAR017 (autologous T cells expressing anti-CD19 chimeric antigen receptor) in adult subjects with aggressive B-NHL (diffuse large B-cell lymphoma (DLBCL) NOS [de novo or transformed follicular lymphoma (tFL)], double/triple-hit lymphoma [DHL/THL], follicular lymphoma Grade 3B [FL3B], primary central …

Georgetown University Medical Center
 (7.9 away)
  • 268 views
  • 07 Nov, 2020
  • +15 other locations
featured
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (TRIPLE)

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (TRIPLE)

The Center for Rheumatology and Bone Research
 (8.5 away) Contact site
  • 184 views
  • 23 Nov, 2020
  • 1 location
featured
12 Month to assess the clinical and economic outcomes of Vectra DA guided treatment compared with usual care in subject with Rheumatoid Arthritis with inadequate response to MTX

12 Month to assess the clinical and economic outcomes of Vectra DA guided treatment compared with usual care in subject with Rheumatoid Arthritis with inadequate response to MTX

The Center for Rheumatology and Bone Research
 (8.5 away) Contact site
  • 424 views
  • 08 Nov, 2020
  • 1 location
featured
Disease Modification in Sjogren's Syndrome Measured by Ultrasound

Disease Modification in Sjogren's Syndrome Measured by Ultrasound

The Center for Rheumatology and Bone Research
 (8.5 away) Contact site
  • 912 views
  • 08 Nov, 2020
  • 1 location
Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

This is a Phase 2, open-label, multi-center study to evaluate the efficacy and the safety/tolerability of poziotinib in seven patient cohorts for up to 603 previously treated and treatment-nave NSCLC patients. Cohorts 3 and 4 were added with Amendment 1 and three additional cohorts were added with Amendment 2 (Cohorts …

HER2
stage iv non-small cell lung cancer
osimertinib
EGFR
Georgetown University Medical Center
 (7.9 away) Contact site
  • 320 views
  • 20 Sep, 2020
  • +67 other locations
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

The purpose of this study is to evaluate the objective response rate (complete response [CR]+ partial response [PR]) of the selected dose regimen in participants with metastatic or surgically unresectable urothelial cancers that harbor specific FGFR genomic alterations.

erdafitinib
adjuvant chemotherapy
measurable disease
dose regimen
renal function
Georgetown Univ. Medical Center - Lombardi Cancer Center
 (7.9 away) Contact site
  • 40 views
  • 15 Oct, 2020
  • +140 other locations
Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (Geometry Mono-1)

A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) as measured by overall response rate (ORR). The study will also evaluate safety and pharmacokinetics of INC280.

measurable disease
alopecia
metastasis
EGFR
Georgetown University Lombardi Cancer Center
 (7.8 away) Contact site
  • 186 views
  • 26 Oct, 2020
  • +162 other locations
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole Based on Prior Endocrine Therapy in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

Study assessing the efficacy and safety of alpelisib plus fulvestrant or letrozole, based on prior endocrine therapy, in patients with PIK3CA mutation with advanced breast cancer who have progressed on or after prior treatments

measurable disease
gonadotropin releasing hormone
estradiol
advanced breast cancer
endocrine therapy
Holy Cross Hospital Pharmacy
 (6.2 away) Contact site
  • 506 views
  • 19 Aug, 2020
  • +118 other locations
Treatment of Hemochromatosis

This study will evaluate the effectiveness of a test called MCV in guiding phlebotomy (blood drawing) therapy in patients with hemochromatosis an inherited disorder that causes too much iron to be absorbed by the intestine. The excess damages body tissues, most severely in the liver, heart, pancreas and joints. Because …

National Institutes of Health Clinical Center, 9000 Rockville Pike
 (9.7 away) Contact site
  • 4 views
  • 05 Nov, 2020
  • 1 location